Market Tracker

09/30 5:16pm ET

Alere Inc (NYSE:ALR)

43.24
Delayed Data
As of Sep 30
 +0.45 / +1.05%
Today’s Change
31.47
Today|||52-Week Range
54.13
+10.62%
Year-to-Date
Mediation Talks Between Abbott and Alere Collapse
Sep 28 / TheStreet.com - Paid Partner Content
J&J (JNJ) to Buy Abbott's Vision Care Unit for $4.3 Billion
Sep 19 / Zacks.com - Paid Partner Content
Johnson & Johnson's Smart (Yet Surprising) Acquisition
Sep 20 / MotleyFool.com - Paid Partner Content
Abbott Labs/Alere: before and after
Sep 01 / FT.com - Paid Partner Content

Today’s Trading

Previous close42.79
Today’s open42.65
Day’s range42.60 - 43.27
Volume372,777
Average volume (3 months)991,834
Market cap$3.7B
Dividend yield--
Data as of 4:02pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-212.07%
Earnings growth (this year)-43.98%
Earnings growth (next 5 years)+8.35%
Revenue growth (last year)-4.77%
P/E ratioNM
Price/Sales1.36
Price/Book2.55

Competitors

 Today’s
change
Today’s
% change
NEOGNeogen Corp+1.99+3.69%
AAAPAdvanced Accelerator...-0.38-0.99%
MYGNMyriad Genetics Inc-0.12-0.58%
VIVOMeridian Bioscience ...+0.02+0.10%
Data as of 4:14pm ET, 09/30/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.55
Annual revenue (last year)$2.5B
Annual profit (last year)-$16.0M
Net profit margin-0.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Namal Nawana
Senior Vice President-
Global Operations
Mark Gladwell
Corporate headquarters
Waltham, Massachusetts

Forecasts